New Report
Biotechnology & Pharmaceuticals Report
November 16, 2010
6 leading Analysts; and top management from 19 Sector Firms examine this vital industry
» See all the topics and companies covered
-
Nextech Invest Ltd. - Dr. Alfred Scheidegger
Dr. Alfred Scheidegger
-
Optimism And A Blockbuster Patent Cliff Lineup In Biotech - Michael Yee - Rbc Capital Markets
Michael Yee - Rbc Capital Markets
-
Orphan Drugs:
today's Hot Biotech Story - Dr. Kimberly Lee - Global Hunter Securities, LlcDr. Kimberly Lee - Global Hunter Securities, Llc
-
A Focus On Long-term Growth In Biotech - Dr. Jason Kantor - Rbc Capital Markets
Dr. Jason Kantor - Rbc Capital Markets
-
Continued M&a Activity In The Specialty Pharma Space - David Amsellem - Piper Jaffray & Co.
David Amsellem - Piper Jaffray & Co.
-
Building Biotech Pipelines And M&a - Robyn Karnauskas - Deutsche Bank Ag
Robyn Karnauskas - Deutsche Bank Ag
-
Genesis Biopharma, Inc. - Robert Brooke
Robert Brooke
-
Amarillo Biosciences, Inc. - Dr. Joseph Cummins
Dr. Joseph Cummins
-
Angiogenex, Inc. - Dr. William Garland
Dr. William Garland
-
Cellceutix Corporation - George Evans
George Evans
-
Puramed Bioscience, Inc. - Russell Mitchell
Russell Mitchell
-
Adventrx Pharmaceuticals, Inc. - Brian Culley
Brian Culley
-
China Bct Pharmacy Group, Inc. - Shelly Zhang
Shelly Zhang
-
Zalicus Inc. - Dr. Mark Corrigan
Dr. Mark Corrigan
-
Pozen, Inc. - Elizabeth A. Cermak
Elizabeth A. Cermak
-
Quick-med Technologies, Inc. - J. Ladd Greeno
J. Ladd Greeno
-
Protea Biosciences, Inc. - Stephen Turner
Stephen Turner
-
Cytosorbents Corporation - Dr. Phillip Chan
Dr. Phillip Chan
-
International Stem Cell Corporation - Brian Lundstrom
Brian Lundstrom
-
Cardiovascular Systems, Inc. - Dave Martin
Dave Martin
-
Biotime, Inc. - Dr. Michael D. West
Dr. Michael D. West
-
Achillion Pharmaceuticals, Inc. - Michael Kishbauch
Michael Kishbauch
-
Apricus Biosciences, Inc. - Edward Cox
Edward Cox










